Olema Pharmaceuticals (OLMA) Operating Expenses (2020 - 2026)
Olema Pharmaceuticals (OLMA) posted quarterly Operating Expenses of $58.0 million for Q1 2026, up 66.28% year-over-year from $34.9 million in Q1 2025, and up 15.78% quarter-over-quarter from $50.1 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Operating Expenses (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported Operating Expenses for 7 consecutive years, with $58.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 66.28% year-over-year to $58.0 million; the TTM figure through Mar 2026 stood at $201.8 million (up 41.33% YoY), while the FY2025 annual figure was $178.7 million, up 25.62% from the prior year.
- Operating Expenses climbed to $58.0 million in Q1 2026 per OLMA's latest filing, from $50.1 million in the prior quarter.
- Across five years, Operating Expenses topped out at $58.0 million in Q1 2026 and bottomed at $21.6 million in Q2 2023.
- Historically, Operating Expenses has averaged $34.8 million across 5 years, with a median of $33.5 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 101.51% — and 2023, when it tumbled 35.12%.
- Olema Pharmaceuticals' Operating Expenses stood at $27.2 million in 2022, then climbed by 11.75% to $30.4 million in 2023, then advanced by 20.88% to $36.8 million in 2024, then soared by 36.22% to $50.1 million in 2025, then grew by 15.78% to $58.0 million in 2026.
- Business Quant data shows OLMA's Operating Expenses at $58.0 million in Q1 2026, $50.1 million in Q4 2025, and $45.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Olema Pharmaceuticals | 930.10 Mn | 930.10 Mn | - | 67.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67.18 Mn |
| Mar 31, 2026 | 57.99 Mn |
| Dec 31, 2025 | 50.08 Mn |
| Sep 30, 2025 | 45.88 Mn |
| Jun 30, 2025 | 47.86 Mn |
| Mar 31, 2025 | 34.87 Mn |
| Dec 31, 2024 | 36.77 Mn |
| Sep 30, 2024 | 37.62 Mn |
| Jun 30, 2024 | 33.53 Mn |
| Mar 31, 2024 | 34.34 Mn |
| Dec 31, 2023 | 30.42 Mn |
| Sep 30, 2023 | 23.34 Mn |
| Jun 30, 2023 | 21.60 Mn |
| Mar 31, 2023 | 29.60 Mn |
| Dec 31, 2022 | 27.22 Mn |
| Sep 30, 2022 | 23.22 Mn |
| Jun 30, 2022 | 33.29 Mn |
| Mar 31, 2022 | 23.25 Mn |
| Dec 31, 2021 | 21.76 Mn |
| Sep 30, 2021 | 17.76 Mn |